Date of event
Thursday, July 14, 2022 - 5:00 pm -
Thursday, July 14, 2022 - 6:00 pm
Continuing Education Credits
Add to Calendar 2022-07-14 17:00:00 2022-07-14 18:00:00 Webinar: Management of Autoimmune Hepatitis Not Achieving Remission AASLD America/New_York public

Content Contributor

Clinical Practice SIG


  • John M. Vierling, MD, FACP, FAASLD. AGAF


  • Paul J. Thuluvath, MD
  • Stephen E. Congly MD, MSc, FRCPC


Ascites is a common complication and often the first sign of decompensation in patients with End-Stage Liver Disease. Management of ascites is often fraught with complex challenges including electrolytes imbalances, renal failure, hepatic encephalopathy, and significant utilization of resources. A proportion of the patients do not respond to conventional diuretic therapy (refractory ascites)y or develop significant sides effects that limit the optimal dosing of the diuretics leading to suboptimal control of ascites ( intractable ascites). We would like to review recent advances in the management of refractory/intractable ascites.